Nevertheless, a thorough analysis of a human hyperbilirubinemia dataset and the respective OATP1B1 and OATP1B3 inhibition predictions (Kotsampasakou et al., 2017a) indicated no strong association between OATP inhibition and hyperbilirubinemia, either for humans or for animals (Kotsampasakou et al., 2017b). Here, SLCO1B3 is linked to Hyperbilirubinemia.